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Available online 11 June 2016AbstractPurpose: To evaluate modes of cataractogenesis in the hypertensive state by using different hypertensive animal models, including fructose,
cadmium chloride (CdCl2), Nu-nitro-L-arginine methyl ester (L-NAME), and two-kidney, one clip (2K1C) method.
Methods: Male SpragueeDawley albino rats (150e180 g) were divided into different groups, each group containing six animals. Hypertension
was induced in animals via six weeks administration of fructose (10% solution in drinking water), CdCl2 (0.5 mg/kg/day, i.p.), and L-NAME
(20 mg/kg/day, p.o.) in their respective groups and NaCl (0.9% solution in drinking water) in the 2K1C group. The Ramipril-treated group
(2 mg/kg/day, orally) served as a standard group for the 2K1C animal model. Blood pressure was measured biweekly using non-invasive blood
pressure system. The biochemical parameters in serum and eye lenses were evaluated after six weeks of the experimental protocol.
Results: Hypertensive animal models showed significant induction of systolic and diastolic blood pressure and modulation of oxidative stress
through depletion of antioxidants, including glutathione peroxidase, catalase, superoxide dismutase, glutathione, and elevation of malondial-
dehyde in serum and eye lenses. A significant elevation of ionic contents (Naþ and Ca2þ) and reduction of total protein and Ca2þ ATPase activity
in eye lenses were observed in all hypertensive animal models except L-NAME when compared with the normal group. The significant
restoration of the antioxidants, Malondialdehyde (MDA) total protein, and ionic contents in the eye lenses concomitant with reduction of blood
pressure were observed in the ramipril-treated group as compared to the 2K1C animal model. The results indicate that the fructose, CdCl2, and
2K1C models showed pronounced cataractogenic effects in the rat eye lenses.
Conclusion: Based on our findings, it can be concluded that systemic hypertension significantly increases the risk of cataract formation in the rat
eyes via modulation of the antioxidant defense mechanism and electrolyte homeostasis.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).blind is expected to increase dramatically in coming decades
as the number of elderly in the world's population increases. It
is suggested that the number of cataract-blind could reach
close to 40 million by the year 2025.2 There are several risk
factors which are associated with induction of cataracto-
genesis, such as diabetes, oxidative stress, ultraviolet radia-
tion, age, etc.3 Several epidemiological studies revealed that
hypertension is also associated with cataract, but sometimes it
is significant1,4,5 and sometimes not.6 Their studies, however,
lacked the exact exploitation of biological mechanism
involved in the entire process regarding the exacerbation of
cataract in hypertensive state. Some preclinical studiessting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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homeostasis through inhibition of Naþ Kþ ATPase pump ac-
tivity in the lens which causes the cataract formation,7 but at
present, another possible mechanism involved in cataracto-
genesis through hypertension is still unclear. In this perspec-
tive, we designed an experimental study to evaluate modes of
cataractogenesis in the hypertensive state by using different
hypertensive animal models, such as fructose, cadmium
chloride (CdCl2), Nu-nitro-L-arginine methyl ester (L-NAME),
and two-kidney, one clip (2K1C), which have different modes
of cellular pathogenesis. In fructose animal model, chronic
fructose administration induces hypertension by systemic
oxidative stress, sympathetic overactivity, and increased pro-
duction of vasoconstrictor molecules, viz endothelin-I and
angiotensin-II.8 CdCl2 induced hypertension is related to Ca
2þ
mimicking contractile activity of cadmium ion on vascular
smooth muscles,9 oxidative damage, and vascular endothelial
dysfunction.10 The 2K1C model elevates the plasma renin
activity, which activates the angiotensin II-mediated hyper-
tensive actions,11 and L-NAME modulates the nitric oxide
(NO) level in smooth muscles, which lead to elevation of
blood pressure.12
MethodsDrugs and chemicalsL-NAME was purchased from SigmaeAldrich (St. Louis,
MO, USA). D-fructose and CdCl2 were purchased from
HiMedia chemicals (Mumbai, India). Ramipril was obtained
from Cipla Limited (Mumbai, India) as a gift sample. Other
chemicals and reagents used were of analytical grade.Experimental animalsSpragueeDawley albino male rats (150e180 g) were used
for the experimental study and were housed under standard
environmental condition (23 ± 2 C, with 55 ± 5% humidity
and 12 h light/dark cycle) according to the guidelines of
Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA), Govt. of India, and were
fed a standard pellet diet with water ad libitum under hygienic
conditions. Animals were habituated to laboratory conditions
for at least 48e72 h prior to the experimental protocol to
minimize non-specific stress, if any. The protocol was
approved by the Institutional Animal Ethics Committee
(IAEC) of Institute of Pharmaceutical Science, Guru Ghasidas
Vishwavidyalaya, Bilaspur (C.G), India (Reg. No.-994/GO/
ERe/S/06/CPCSEA), and the experiments were conducted
according to the ethical principles and guidelines provided by
CPCSEA, Govt. of India and the Association for Research in
Vision and Ophthalmology (ARVO) for animals.Experimental designMale SpragueeDawley albino rats (150e180 g) which
were normal regarding the ocular examination and bloodpressure at the baseline were randomly selected and divided
into six different groups, each group containing six animals.
Hypertension was induced in animals via six-week admin-
istration of fructose (10% solution in drinking water) in
group II,13 CdCl2 (0.5 mg/kg/day, i.p.) in group III,
9
L-
NAME (20 mg/kg/day, p.o.) in group IV14, and in group V,
hypertension was induced by 2K1C animal model.15 The
ramipril-treated group (2 mg/kg/day, p.o.) served as standard
group (2K1C animal model).16 Group I served as normal
control.
The systolic (SBP) and diastolic blood pressure (DBP) in
each group were monitored biweekly via non-invasive
blood pressure system (NIBP; CODA-08 Channel, Kent
scientific, USA), and biochemical parameter in serum and
eye lens were determined after six weeks in sacrificed
animals.Surgical procedure for 2K1C model2K1C was performed on all the rats by anesthetizing with
ketamine and xylazine (60:10 mg/kg, i.p.). The kidney was
visualized by a left lateral abdominal incision, and the left
renal artery and ureter were ligated by a silk thread. The
muscle and skin layer (incision site) were sutured with highly
sterile suture needles. After surgery, rats were allowed to drink
water ad libitum, with no further treatment. All unin-
ephrectomized animals were given 0.9% NaCl in the drinking
water for six consecutive weeks.15Blood collectionAnimals were sacrificed after six weeks, blood was
collected from each group via cardiac puncture, and serum
was separated and stored at 2e8 C for further biochemical
analysis.Preparation of lens homogenateThe eyeball was isolated from the sacrificed animals.
Lenses were dissected via posterior approach, washed with
cold saline, and stored with saline at 20 C until analysis.
Lens homogenate was prepared from both lenses of each an-
imal in 10 volumes of 0.1 M potassium phosphate buffer (pH
7). The homogenate was centrifuged at 10,000 rpm for 1 h,
and the supernatant was separated and used for biochemical
analysis.17Determination of lenticular opacityThe lenticular opacity of the experimental groups was
determined by the photographic method based on the
appearance of graph lines through the lens. The eye lenses
were dissected via a posterior approach, put on graph paper
immediately, and photographed by a digital camera (Sony
Cybershot DSC-W810). The graph lines would appear clearly
in the transparent lens and cloudy or not visible in the cata-
ractous lens.18
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Enzymatic and non-enzymatic antioxidants in serum and
lens
Glutathione peroxidase (GPx). The activity of the GPx was
assayed by using the method of Tappel, (1978). Briefly, 0.2 ml
of the test sample was reacted with 0.2 ml of 0.4 M tris buffer,
0.1 ml of 10 mM sodium azide, 0.1 ml of 0.2 mM hydrogen
peroxide, and 0.2 ml of glutathione. The reaction mixture was
incubated at 37 C for 10 min, and then reaction was arrested
by the addition of 0.4 ml of 10% trichloroacetic acid (TCA).
The absorbance was read at 340 nm.19
Catalase (CAT). The CAT activity was monitored at 240 nm
for 30 s at 25 C by using the method of Aebi et al (1984). One
unit of CAT is defined as the amount of enzyme required to
decompose 1.0 M of hydrogen peroxide into water per minute
at pH 7.0 and 25 C.20
Superoxide dismutase (SOD). The reaction mixture contained
1 ml of homogenate (10% w/v in 0.25 M sucrose buffer),
1.2 ml of sodium pyrophosphate buffer (0.052 M, pH 8.3),
0.1 ml of 186 mM phenazonium methosulphate, 0.3 ml of
300 mM nitro blue tetrazolium, and 0.2 ml of 780 mM NADH.
The reaction mixture was diluted up to 3 ml by distilled water
and incubated at 30 C for 60 s. The reaction was arrested by
addition of 1.0 ml glacial acetic acid and stirred vigorously.
4.0 ml of n-butanol was added to the mixture, shaken well,
allowed to stand for 10 min, and centrifuged at 2500 rpm for
5 min. Butanol layer was separated out, and absorbance was
measured at 560 nm against a butanol blank. Xanthine oxidase
enzyme served as the control.21
Glutathione (GSH). The lens and serum glutathione level were
measured using Ellman's reagent (Ellman, 1959). Briefly, the
homogenized lens (10% w/v in cold 20 mM EDTA) and serum
were deproteinized with 0.5 ml of 10% TCA and centrifuged.
The protein free supernatant (0.2 ml) was treated with 4 ml of
0.3 M Na2HPO4 (pH 8.0) and 0.5 ml of 0.04% (w/v) 5, 5’-
dithiobis (2-nitrobenzoic acid) (Ellman's reagents). The absor-
bance was measured at 412 nm. The pure glutathione was used
as a standard for establishing the calibration curve.22Malondialdehyde (MDA) in serum and lensMDA, an end product of lipid peroxidation, was estimated in
the lens homogenate and serum by using the method of Ohkawa
(1979). Briefly, 0.2 ml of test sample was reacted with 0.2 ml of
8.1% sodium dodecyl sulphate, 1.5 ml of 20% acetic acid (pH
3.5), and 1.5 ml of 0.81% thiobarbituric acid in succession. The
mixture was heated in boiling water for 60 min. After cooling at
room temperature, 5 ml of butanol: pyridine (15:1 v/v) solution
was added, and the mixture was centrifuged at 5000 rpm for
15min. The upper organic layer was separated out, and intensity
of the resultant pink color was read at 532 nm. Tetra methoxy
propane was used as a standard.23Total protein content in lensThe total protein content was measured by using the
method of Lowry et al (1951). Briefly, 0.1 ml of lens ho-
mogenate was treated with 4.0 ml of alkaline copper solution
and allowed to stand for 10 min, and then 0.4 ml of phenol
reagent was added very rapidly, mixed quickly, and incubated
at room temperature for 30 min for color development. The
absorbance of the resultant color product was measured at
610 nm against blank. Bovine serum albumin was used as a
standard for establishing the calibration curve.24Ca2þ ATPase activity in lensThe Ca2þ ATPase activity was determined by using the
method of Rorive and Kleinzeller (1974). Briefly, 0.1 ml of
the lens homogenate (10% w/v in 0.25 M sucrose) was
treated with 0.2 ml of ATP (40 mM in 0.4 M triseHCl buffer,
pH 7) and incubated at 37 C in a water bath for 30 min. The
enzyme activity was stopped by adding 2 ml of 10% TCA,
and 0.2 ml of ATP was added and kept in ice for 20 min. The
reaction mixture was centrifuged at 2500 rpm for 10 min, and
the supernatant was collected. 3 ml of supernatant was
treated with 1 ml of 2.5% ammonium molybdate and 0.4 ml
of amino naphthol sulfonic acid. The absorbance of the
resultant color product was measured at 680 nm after
20 min.25Ionic contents (Naþ and Ca2þ)Ionic contents of the serum and lens were estimated by
spectrophotometric method using diagnostic kits (Labcare
Diagnostics Pvt. Ltd., India).Statistical analysisThe results were expressed as mean ± standard error of
mean (SEM). The significant differences between multiple
groups were statistically analyzed by using one-way and two-
way analysis of variance (ANOVA). The data were considered
statistically significant at p < 0.05. Statistical analysis was
performed using Graph Pad Prism 5.0 software (GraphPad
software, Inc., USA).
ResultsEffects on blood pressureDuring six weeks of experimental protocol, blood pressure
(SBP and DBP) was found to increase significantly in a time-
dependent manner in each group (except the ramipril-treated
group) as compared to the normal group. CdCl2 and L-
NAME models showed a significant increase in SBP
(p < 0.001, p < 0.05) and DBP (p < 0.001, p < 0.001) from the
second week, respectively, whereas the fructose and 2K1C
models showed significant elevation in SBP (p < 0.001) and
DBP (p < 0.001) from the fourth week. The ramipril-treated
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DBP as compared to 2K1C (Fig. 1).Effects on lens opacityThe eye lenses of hypertensive animals (Fig. 2 B to E) were
more opaque than the normal control (Fig. 2 A). The eye
lenses of fructose, CdCl2, and 2K1C hypertensive animal
models were more opaque than the lenses of the L-NAME
animal model. The administration of ramipril to 2K1C hy-
pertensive animals showed substantial reduction in lenticular
opacity as compared to 2K1C (Fig. 2 F).Effects on biochemical parameters in serumThe significant augmentation in systemic oxidative stress was
observed in all hypertensive animal models (Table 1). Fructose,
CdCl2, and 2K1C models showed significant (p < 0.001)
depletion of serum enzymatic antioxidants (GPx, CAT, and
SOD) in serum while L-NAME showed depletion in CAT
(p < 0.01) and SOD (p < 0.01) only when compared to normal.
The level of non-enzymatic antioxidant (GSH) and an end
product of lipid peroxidation, MDAwere significantly reduced
in fructose (p < 0.01, p < 0.001), CdCl2 (p < 0.01, p < 0.05),
L-NAME (p < 0.05, p < 0.05), and 2K1C (p < 0.001, p < 0.01)
models, respectively, when compared to normal (Table 1). The
ramipril-treated group showed significant elevation in serum
GPx (p < 0.01), CAT (p < 0.01), SOD (p < 0.001), and GSH
(p < 0.001) level and reduction in serum MDA (p < 0.01) level
as compared to the 2K1C group.Effects on biochemical parameters in eye lensesThe hypertensive animal models showed marked oxidative
stress via attenuation in enzymatic and non-enzymatic antioxi-
dants in rat eye lenses (Table 2). The fructose, CdCl2, and 2K1C
models showed significant (p < 0.001) reduction in GPx, CAT,
SOD, andGSH levels, while L-NAMEmodel showed significant
reduction in GPx (p < 0.05), CAT (p < 0.001), and SOD
(p < 0.05) only when compared to normal.Fig. 1. Effects of hypertensive animal models on (A) systolic blood pressure and (
mean (n ¼ 6), ap< 0.05, bp < 0.01, cp < 0.001 when compared to normal and dp < 0
by Bonferroni's post hoc test).MDA level (Table 2) was significantly increased in fructose
(p < 0.001), CdCl2 (p < 0.05), 2K1C (p < 0.001), and L-
NAME (p < 0.01) models. The total protein content and Ca2þ
ATPase activity in eye lenses were significantly reduced in
fructose (p < 0.001, p < 0.01), CdCl2 (p < 0.001, p < 0.001),
and 2K1C (p < 0.001, p < 0.01) models, respectively, whereas
L-NAME showed non-significant reduction as compared to
normal (Fig. 3).
The significant (p < 0.001) elevation of serum antioxidants
(GPx, CAT, SOD, and GSH) and depletion of MDA level were
observed in ramipril-treated rats. Moreover, total protein
content (p < 0.001) and Ca2þ ATPase activity (p < 0.01) in
eye lenses were significantly increased by ramipril in 2K1C
hypertensive animal model.Effects on ionic (Naþ and Ca2þ) contentsIonic contents in serum and lens were altered markedly in
CdCl2 and 2K1C models than fructose and L-NAME models
(Fig. 4). Serum Naþ level was significantly (p < 0.01)
increased in CdCl2 and 2K1C models whereas its level was
unaffected in fructose and L-NAME models. Lens Naþ was
also significantly increased by fructose (p < 0.05), CdCl2
(p < 0.001), and 2K1C (p < 0.001) while L-NAME failed to
show the significant effect as compared to normal. Serum
Ca2þ was significantly (p < 0.05) reduced in CdCl2 model
only whereas lens Ca2þ was significantly increased in fructose
(p < 0.05), CdCl2 (p < 0.001), and 2K1C (p < 0.01) models
when compared to normal. The significant restoration of Naþ
(p < 0.001) in serum and lens, and Ca2þ (p < 0.01) in the lens
was observed in the ramipril-treated group.
Discussion
In the present study the fructose, CdCl2, L-NAME, and
2K1C hypertensive animal models showed significant in-
crease in hypertension in terms of elevation of SBP and DBP
during six weeks of the experimental protocol. The mode of
induction of hypertension was independent in each animal
model.B) diastolic blood pressure. Values are expressed as mean ± standard error of
.05, ep < 0.01, fp < 0.001 when compared to 2K1C (two-way ANOVA followed
Fig. 2. Effects on lenticular opacity, (A) Normal, (B) Fructose, (C) CdCl2, (D) L-NAME, (E) 2K1C, and (F) Ramipril.
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cies (ROS) level is increased in the chronic hypertensive state
that is indicated by depletion of serum antioxidants and
elevation of MDA level. The increased blood pressure
markedly produces the ROS through vascular stimulation by
mechanical stretch and activation of the renin-angiotensin
system and further leads to oxidative stress.26e28 In our
study, we found that chronic hypertension in different animal
models significantly augmented the oxidative stress as indi-
cated by depletion of antioxidants (SOD, GPx, CAT, and
GSH) and elevation of MDA level in serum. The reduced
serum antioxidants via hypertension may further lead to
cellular damage of several organs, including the eye lenses
via modulation of antioxidant defense mechanism that is
confirmed by depleting antioxidants and elevating MDA level
in the eye lenses.29,30
The increased oxidative stress and ionic imbalance in len-
ses are key mechanisms for the development of cataract; it can
modulate the protein content and lenticular opacity.31e33 The
increased ROS in the lens can cause the molecular damage of
lens protein and phospholipids leading to lipid peroxidation
and depletion of the antioxidant enzymes such as SOD, GPx,Table 1
Effects on GPx, CAT, SOD, GSH, and MDA level in serum.
Group GPx (mM/min/mg of Hb) CAT (mM of H2O2
consumed/min/mg of Hb)
Normal 5.07 ± 0.33 0.53 ± 0.03
Fructose 2.40 ± 0.19c 0.34 ± 0.02c
CdCl2 3.47 ± 0.27
c 0.38 ± 0.02c
L-NAME 4.75 ± 0.21 0.41 ± 0.01b
2K1C 3.48 ± 0.20c 0.36 ± 0.03c
Ramipril 4.76 ± 0.13e 0.48 ± 0.02e
Values are expressed as mean ± standard error of mean (n ¼ 6), ap< 0.05, bp < 0.0
when compared to 2K1C (one-way ANOVA followed by NewmaneKeuls post hoc t
NAME: Nu-nitro-L-arginine methyl ester; MDA: Malondialdehyde; SOD: superoxand CAT, resulting in elevation of lenticular opacity and
cataract formation.34,35 SOD is a chain-breaking antioxidant.
It converts superoxide to H2O2 and scavenges the superoxide
anion to form hydrogen peroxide,36 GPx is responsible for
degrading the level of H2O2,
37 and CAT helps to keep the level
of free radicals below toxic levels.38 Thus, enhanced oxidative
stress in lens induced by hypertension might be responsible for
the risk of cataract formation. Moreover, ramipril, an
angiotensin-converting enzyme (ACE) inhibitor administered
to the 2K1C-induced hypertensive animals, significantly
restored the serum and lens antioxidants and MDA level
concomitant with reduction of blood pressure, suggesting that
high blood pressure is potentially associated with increased
ROS formation in serum and lens and further leads to cata-
ractogenic effects on eye lenses.
The elevated MDA level and reduced GSH level in hy-
pertensive rat lenses also implicated the progression of cata-
ractogenesis in rats. The reduced level of GSH is anticipated to
cause the formation of disulphide bonds through sulfhydryl
oxidation of lens crystalline and to cause the cross-linkage,
which leads to cataract formation39 whereas increased level
of MDA, a product of membrane lipid peroxidation, causes theSOD (mM/min/mg of Hb) GSH (mM/ml) MDA (mM/ml)
2.11 ± 0.06 2.56 ± 0.14 2.63 ± 0.12
1.05 ± 0.07c 1.65 ± 0.14b 5.04 ± 0.38c
1.35 ± 0.14c 1.73 ± 0.11b 3.81 ± 0.24a
1.59 ± 0.11b 2.33 ± 0.16 3.43 ± 0.26a
1.24 ± 0.13c 1.17 ± 0.07c 4.21 ± 0.35b
1.89 ± 0.07f 2.29 ± 0.13f 2.77 ± 0.17e
1, cp < 0.001 when compared to normal and dp < 0.05, ep < 0.01, fp < 0.001
est). CAT: catalase; GPx: glutathione peroxidase; GSH: reduced glutathione; L-
ide dismutase; 2K1C: two-kidney, one clip.
Table 2
Effects on GPx, CAT, SOD, GSH, and MDA level on rat eye lenses.
Group GPx (mM/min/mg protein) CAT (mM of H2O2
consumed/min/mg protein)
SOD (mM/min/mg protein) GSH (mM/mg protein) MDA (mM/mg protein)
Normal 3.69 ± 0.24 0.46 ± 0.02 2.74 ± 0.05 2.68 ± 0.17 0.35 ± 0.023
Fructose 1.69 ± 0.08c 0.26 ± 0.01c 0.82 ± 0.02c 1.54 ± 0.09c 0.61 ± 0.020c
CdCl2 1.14 ± 0.07
c 0.30 ± 0.01c 1.89 ± 0.04c 1.14 ± 0.21c 0.45 ± 0.02a
L-NAME 3.07 ± 0.16a 0.25 ± 0.03c 2.52 ± 0.05a 2.28 ± 0.22 0.47 ± 0.01b
2K1C 1.69 ± 0.04c 0.18 ± 0.02c 1.73 ± 0.05c 0.87 ± 0.04c 0.64 ± 0.02c
Ramipril 3.42 ± 0.20f 0.40 ± 0.01f 2.55 ± 0.05af 2.35 ± 0.20f 0.38 ± 0.01f
Values are expressed as mean ± standard error of mean (n ¼ 6), ap< 0.05, bp < 0.01, cp < 0.001 when compared to normal and dp < 0.05, ep < 0.01, fp < 0.001
when compared to 2K1C (one-way ANOVA followed by NewmaneKeuls post hoc test). CAT: catalase; GPx: glutathione peroxidase; GSH: reduced glutathione; L-
NAME: Nu-nitro-L-arginine methyl ester; MDA: Malondialdehyde; SOD: superoxide dismutase; 2K1C: two-kidney, one clip.
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membrane lipids and proteins.40
The transparency of the lens is also dependent on protein
content and intracellular ions, especially Ca2þ and Naþ.
Accumulation of these ions leads to the aggregation of lens
proteins and further reduces the total and soluble proteins, and
increases the insoluble proteins, and causes lenticular opacity.
The activation of calpain via increased Ca2þ in lens leads to
enhanced proteolytic activity in lens epithelial cell that results
in digestion of cytoskeletal and junctional proteins and initi-
ates lenticular opacity.32,33 As a limitation in our study, we
estimated the lens total protein content only instead of soluble/
insoluble proteins, which are more relevant to the cataracto-
genesis. In our studies, we found that lens Ca2þ and Naþ were
noticeably enhanced, and total protein was markedly reduced
in fructose, CdCl2, and 2K1C animal models than the L-NAME
animal model. The accumulation of Ca2þ is caused by the
reduction of Ca2þ ATPase activity,41 and accumulation of Naþ
ion is related to the impairment of NaþKþ ATPase activity.33
The restoration of elevated Ca2þ and Naþ in the eye lenses of
the 2K1C hypertensive animals were observed concomitant
with the elevation of total protein content in the lens by
administration of ramipril, suggesting that reduction of lens
protein content might be due to the enhanced level of Ca2þ
and Naþ in eye lenses.Fig. 3. Effects on (A) total protein content and (B) Ca2þ ATPase activity in rat eye le
bp< 0.01, cp< 0.001when compared to normal and dp< 0.05, ep< 0.01, fp< 0.001w
test).The possible mode of cataractogenesis through hyperten-
sion might be different for each animal model. Fructose ani-
mal model causes marked oxidative stress and ionic imbalance
in eye lenses. Additionally, fructose is an end product of
polyol pathway of glucose metabolism in the lens and further
leads to the formation of ROS and advanced glycation end
products (AGE)42,43 that may exacerbate the cataractogenic
effects of hypertension.
CdCl2-induced cataractogenic effects through hypertension
might be related to their over intracellular Ca2þ ion-dependent
cataractogenic actions that lead to oxidative damage, dereg-
ulating ATPase pumps in the eye lenses. In addition, re-
searchers also reported that cadmium (Cd2þ) induces the lens
epithelial cell death due to enhanced oxidative stress and lipid
peroxidation.44 Thus, the observation of cataractogenesis in
CdCl2-treated rats may be due to the primary toxicity of the
(Cd2þ) that may produce oxidative damage to the vascular
walls and eye lenses, and further leads to hypertension and
cataractogenesis.
The cataractogenic effects of 2K1C hypertensive animal
model might be related to the hyperactivity of the ocular renin-
angiotensin system. It is established that 2K1C trigger the
angiotensin II-mediated actions. The literature revealed that
serum angiotensin-II cannot enter the eye,45 but it can
modulate the action of ocular renin-angiotensin system46 andnses. Values are expressed as mean ± standard error of mean (n¼ 6), ap< 0.05,
hen compared to 2K1C (one-wayANOVA followed byNewmaneKeuls post hoc
Fig. 4. Effects on (A) Naþ and (B) Ca2þ in serum and eye lenses. Values are expressed as mean ± standard error of mean (n ¼ 6), ap < 0.05, bp < 0.01, cp < 0.001
when compared to normal and dp < 0.05, ep < 0.01, fp < 0.001 when compared to 2K1C (one-way ANOVA followed by NewmaneKeuls post hoc test).
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matory action in the eye through production of vascular
endothelial growth factor,47 mitogen-activated protein ki-
nases,48 and AGE,49 and further lead to the development of
several blinding ocular disorders like diabetic retinopathy,
glaucoma, and macular degenerations.50 In the present study,
inhibition of ACE via ramipril showed protective effects
against 2K1C-induced hypertension associated cataractogenic
action. Moreover, several researchers also found that ACE
inhibitors showed beneficial effects in the reduction of cataract
through restoration of ionic balance (Naþ/Kþ), free radical
scavenging activity, and enhancement of enzymatic and non-
enzymatic defense mechanism as well as inhibition of AGE
production.51,52 Therefore, cataractogenic effects in 2K1C
hypertensive animal model might be related to the action of
ocular renin-angiotensin system that enhances oxidative stress
and ionic imbalance in eye lenses and further leads to the
development of cataract.
In the present study, L-NAME significantly elevated the
blood pressure similar to other animal models but showed
minor reduction of serum and lens antioxidants as compared
to other animal models. It showed non-significant effects on
total protein content and ions level, indicating that L-NAME
independently affects the lenticular alterations. It is estab-
lished that L-NAME produces depletion of the serum NO
level and enhances blood pressure14 whereas increased nitrite
(metabolite of NO) levels in lens causes the cataracto-
genesis.53 In addition, Ito et al reported that NO synthase
inhibitors (L-NAME) prevented the development of cataract
in selenite-treated rats.54 Therefore, it has mild cataracto-
genic effects and might be related to oxidative stress through
hypertension rather than modulation of NO levels via L-
NAME.
The risk of cataractogenesis through hypertension is
dependent on its pathogenesis. Uncontrolled hypertension may
modulate the oxidative stress and electrolyte homeostasis in
the eye lenses and further enhance the risk of cataract for-
mation. Fructose might exacerbate the oxidative damage, and
CdCl2-induced hypertension might up-regulate Ca
2þ activity
and oxidative stress. The 2K1C activates the ocular renin-
angiotensin system in the eye lenses via uncontrolledhypertension and further leads to cataractogenesis whereas L-
NAME independently affects the lenticular alterations unre-
lated to hypertension. In conclusion, systemic hypertension
seems to be a major risk factor that indirectly affects the lens
integrity associated with cataract formation.
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